Luxdegalutamide | MedChemExpress (MCE)
ARV-766 is an orally active and potent proteolysis targeting chimera (PROTAC) protein degrader. ARV-766 degrades wild-type androgen receptor (AR) but also relevant AR LBD mutants, including the most prevalent AR L702H, H875Y, and T878A mutations[1].
Trivial name | Luxdegalutamide |
Catalog Number | HY-153342 |
Alternative Name(s) | ARV-766 |
Research Area | Cancer |
CAS# | 2750830-09-0 |
Purity | 98.18% |
SMILES | CC(C)([C@@H](C1(C)C)NC(C2=CC=C(N3CCC(CC3)CN4CCN(C5=CC(F)=C(C=C5)C(N[C@@H]6C(NC(CC6)=O)=O)=O)CC4)C=C2)=O)[C@@H]1OC7=CC(OC)=C(C=C7)C#N |
PubChem Chemical Structure ID | 156504141 |
Size | 1 mg |
Supplier Page | https://www.medchemexpress.com/arv-766.html |